What price misses that six specialist lenses catch
Price reflects the consensus of all buyers and sellers at that moment. It does not tell you whether that consensus is well-reasoned or fragile. A sleeve sitting at its 52-week low might be genuinely oversold — or it might be pricing in a credit event that hasn't made headlines yet. A sleeve at its high might reflect durable earnings momentum — or reflexive crowding that PSYCHE and NEXUS will flag weeks before a reversal.
Cognitor surfaces those debates across six Panel lenses and five SENIOR verdicts before you trim or add. Both the consensus and the dissenting views are visible — so you know whether you're rebalancing into a strongly contested trade or a broadly supported one.
The six lenses in the context of a portfolio review
Macro and liquidity (HELIOS)
Rates, financial conditions, and cross-asset flows — directly relevant to how your equity and duration sleeves behave in the current rate environment, not just what the chart shows.
Technology cycle and risk (NEXUS)
Whether innovation cycle compensation justifies the risk premium embedded in tech and semiconductor positions — critical if QQQ or SMH are large in your book.
Geopolitics and commodities (ARGOS)
Supply shocks and conflict risk that momentum and price signals frequently underweight until the event is confirmed — relevant for energy, gold, and EM sleeves.
EM and FX flows (VEGA)
Whether global capital is rotating toward or away from emerging markets and how that affects your international developed and EM allocations relative to US core.
Fundamentals vs price (ATHENA)
Whether current valuations and earnings trajectories support the size, style, and sector tilts you hold — the lens that catches expensive-for-a-reason before it becomes expensive-for-no-reason.
Behavior and positioning (PSYCHE)
Crowding, sentiment, and reflexivity — especially important for thematic and high-beta sleeves where narrative momentum can sustain a thesis well past the point fundamentals support it.
Core building blocks investors research before a rebalance
Illustrative tickers from the curated ~40-name universe — not a model portfolio. These represent the major macro backdrops most self-directed books touch at some point: US large cap, tech, international developed, EM, duration, gold, and real assets.
SPY · QQQ · IEF · GLD · VEA · VWO · IWM
- Read Friday's PRIME + tension map for the sleeves you're about to overweight or underweight. Note whether the five SENIOR verdicts are unanimous or split on the risk narrative.
- Weight the divergence — a 5-0 risk flag deserves a different rebalance size than a 3-2 disagreement. PRIME maps this explicitly so you can calibrate position size to consensus strength.
- Execute in your brokerage — tax-lot selection, wash-sale rules, and settlement remain your implementation detail. Cognitor never sees your account or routes orders.
Questions portfolio investors ask
- What if I only hold one or two ETFs? The research is still directly applicable. Map your single fund to the closest US-listed ticker in the universe — SPY for broad US equity,IEF for investment-grade duration — and use the weekly dossier as a macro and valuation checkpoint before any size change.
- How does this differ from a standard brokerage research note? A broker note reflects one analyst or one team's framework, and that team has a financial relationship with the products they cover. Cognitor's six Panel specialists each operate through a different domain lens independently; five SENIOR verdict layers then deliberate on the same evidence without cross-talk. You see both the consensus and the dissent.
- How do I handle taxable rebalancing? Cognitor provides market research, not tax optimization. Wash-sale windows, short- versus long-term capital gain timings, and tax-lot selection are implementation decisions that remain yours — or your tax professional's.
- Can I use this for factor or smart-beta ETFs? Yes, for those in the curated universe. The Panel's valuation (ATHENA) and behavioral (PSYCHE) lenses are especially relevant for factor exposures — factor crowding and mean-reversion risk are explicit parts of the analysis when those tickers are in focus.
Seven days of Pro access gives you the full Friday dossier plus same-day weekday briefings — enough to run one complete rebalance research cycle before deciding whether to stay.
Start Free Research Trial